Company’s 36-month beta value is 1.78.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for AEMD is 13.65M, and currently, short sellers hold a 10.07% ratio of that floaft. The average trading volume of AEMD on February 13, 2025 was 3.35M shares.
AEMD) stock’s latest price update
Aethlon Medical Inc (NASDAQ: AEMD) has seen a decline in its stock price by -4.19 in relation to its previous close of 0.67. However, the company has experienced a -12.97% decline in its stock price over the last five trading sessions. prnewswire.com reported 2025-02-13 that Aethlon Medical invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO, Feb. 13, 2025 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 19, 2025.
AEMD’s Market Performance
AEMD’s stock has fallen by -12.97% in the past week, with a monthly rise of 1.54% and a quarterly rise of 49.85%. The volatility ratio for the week is 9.05% while the volatility levels for the last 30 days are 9.97% for Aethlon Medical Inc The simple moving average for the last 20 days is -6.11% for AEMD stock, with a simple moving average of 23.54% for the last 200 days.
AEMD Trading at 5.57% from the 50-Day Moving Average
After a stumble in the market that brought AEMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.41% of loss for the given period.
Volatility was left at 9.97%, however, over the last 30 days, the volatility rate increased by 9.05%, as shares sank -9.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +51.77% upper at present.
During the last 5 trading sessions, AEMD fell by -14.97%, which changed the moving average for the period of 200-days by -54.02% in comparison to the 20-day moving average, which settled at $0.6809. In addition, Aethlon Medical Inc saw -25.58% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AEMD
The total capital return value is set at -0.0. Equity return is now at value -137.96, with -103.99 for asset returns.
Based on Aethlon Medical Inc (AEMD), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -8.24.
Currently, EBITDA for the company is -11.85 million with net debt to EBITDA at 536.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.06.
Conclusion
In a nutshell, Aethlon Medical Inc (AEMD) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
